GREY:DGCRF - Post by User
Comment by
modulexon Jul 18, 2012 6:29pm
226 Views
Post# 20128501
RE: RE: RE: They made quite an impression !
RE: RE: RE: They made quite an impression ! There is obviously something "questionable" about DIAGNOCURE (T-CUR) depressed stock value. PCA3 will have to demonstrate a sound level of success to spur investors. It has not yet reached that stage. FDA approval took longer than expected because of some controversial delays. Ms. Valerie Palmieri who was appointed (President of DiagnoCure Oncology Laboratories USA) in 2010 and Mrs. Paule De Blois (Vice-President Corporate Affairs) are no longer with the company. Their departures were kept internal. I have written to management in 2011 raising the issue that the company should be acquired as it is just to small to continue on its own.